Randomised controlled trials, including the National Lung Screening Trial (NLST) and the
NELSON trial, have shown reduced mortality with lung cancer screening with low-dose CT …

Notable changes in lung cancer epidemiology and prevention have occurred over the past
decade owing to changes in smoking patterns, groundbreaking advances in our …

Lung cancer is the leading cause of mortality and person‐years of life lost from cancer
among US men and women. Early detection has been shown to be associated with reduced …

Importance Lung cancer is the second most common cancer and the leading cause of
cancer death in the US. In 2020, an estimated 228 820 persons were diagnosed with lung …

Importance The US Preventive Services Task Force (USPSTF) is updating its 2013 lung
cancer screening guidelines, which recommend annual screening for adults aged 55 …

Background Lung cancer is a major health problem. CT lung screening can reduce lung
cancer mortality through early diagnosis by at least 20%. Screening high-risk individuals is …

Background: There are well-documented disparities in lung cancer outcomes across
populations. Lung cancer screening (LCS) has the potential to reduce lung cancer mortality …

Summary Background The Global Registry of Acute Coronary Events (GRACE) 2.0 score
was developed and validated in predominantly male patient populations. We aimed to …

Lung cancer remains the leading cause of cancer related deaths worldwide. Lung cancer
screening using low-dose computed tomography (LDCT) has been shown to reduce lung …

Lung cancer is the leading cause of cancer mortality in the United States. Certain groups are
at increased risk of developing lung cancer and experience greater morbidity and mortality …